This assessment tool is intended to assist countries in conducting an STI surveillance assessment to identify how to best optimize and strengthen existing systems, monitor trends and interpret data to improve STI control programmes.

Both research and consultations over the last decades have identified sexuality-related communication as an issue that requires urgent attention. While clients would like their health-care providers to discuss sexual health concerns...

Cervical cancer is one of the gravest threats to women's lives. It is estimated that over a million women worldwide currently have cervical cancer. Most of these women have not been diagnosed, nor do they have access to treatment that could cure them or prolong their lives. In 2012, 528 000 new cases of cervical cancer were diagnosed, and 266 000 women died of the disease, nearly 90% of them in low- to middle-income countries. Without urgent attention, deaths due to cervical cancer are projected to rise by almost 25% over the next 10 years.

This second edition was developed by WHO and the Global Validation Advisory Committee (GVAC), and is intended for use by national and regional validation committees as they prepare or review national submissions requesting validation of EMTCT of HIV and/or syphilis.

The emergence and spread of human immunodefi ciency virus (HIV) infection and acquired immunodefi ciency syndrome (AIDS) have had a major impact on the management and control of STIs.

This guide, Integrating HPV Testing in Cervical Cancer Screening Programs: A Manual for Program Managers intends to fill this knowledge gap. It provides up-to-date information on HPV testing, to facilitate strengthening cervical cancer screening programs.

 This new manual, Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus, provides a basic understanding of the principles of laboratory tests in the context of screening and diagnostic approaches, as well as antimicrobial susceptibility testing, as components of STI control.

This document has been designed to provide a framework to support local and national STI prevalence studies. The aim of these studies is to understand the burden of disease of Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT), two priority STIs that can cause adverse birth outcomes. For this, the objective is to epidemiologically describe the prevalence of these two infections among pregnant women and, by proxy, the general population in the country.

This training programme is for clinicians and service providers whose normal duties include first-level diagnosis and treatment of patients and those who work as outreach providers, counsellors or educators at any first-contact health facility.

Since the publication of the WHO Guidelines for the management of sexually transmitted infections in 2003, changes in the epidemiology of STIs and advancements in prevention, diagnosis and treatment necessitate changes in STI management.This guideline provides updated recommendations for syphilis screening and treatment for pregnant women based on the most recent evidence and available serologic tests for syphilis.

WHO published interim guidelines on the prevention of sexual transmission of Zika virus in September 2016 (1), based on a limited amount of evidence under an emergency process during a public health emergency of international concern.

These guidelines provide updated treatment recommendations for common infections caused by C. trachomatis based on the most recent evidence; they form one of several modules of guidelines for specific STIs.

These guidelines provide updated treatment recommendations for genital HSV infection based on the most recent evidence; they form one of several modules of guidelines for specific STIs. Other modules will focus on treatments for Neisseria gonorrhoeae (gonorrhoea), C. trachomatis (chlamydial infection) and Treponema pallidum (syphilis).

These guidelines for the treatment of common infections caused by N. gonorrhoeae form one of several modules of guidelines for specific STIs.

These guidelines provide updated treatment recommendations for treatment of Treponema pallidum (syphilis) based on the most recent evidence. They form one of several modules of guidelines for specific STIs.

This document summarizes the new evidencebased WHO recommendations about the use of cryotherapy in women with histologically confirmed CIN for low-, middle- and high income countries.

This document is an update of guidance published on 7 June 2016 to provide advice on the prevention of sexual transmission of Zika virus.